There is mounting evidence for the increasing need for a culturally representative nursing workforce in the United States, especially as our population continues to become more diverse. Between 2000 and 2020, the number of non-white Americans is expected to rise by 50%. Presently there are 35.5 million Hispanics in the United States and many more that are undocumented; it is estimated that by the year 2050, 25% of the U.S. population will be Hispanic. The Asian population has increased by 48% since 1991.^^ To better serve the diverse U.S. population, research nurses should mirror that population. According to the Sullivan Commission, almost 25% of the U.S. population is Hispanic American, AA, and American Indian. However, only 9% of the nursing workforce falls within these ethnic or racial groups. Furthermore, the latest evidence shows that concordance of patient and physician race, ethnicity, and language influences processes of health outcome and participation in research.^'^^'^^ Informal studies from our MB-CCOP have revealed that community-based and hospital-based oncologists are willing to conduct clinical trials; however their main request is for minority CRAs who can support the recruitment and follow up of minority patients and can work effectively with physicians and navigators. In addition, they recommend hiring CRA's who can deliver culturally appropriate interventions and can build trust with the community. To that end, Dillard University, where most minority nurses in Louisiana are trained, is partnering with LSUHSC to develop a program for the certification of CRAs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Exploratory Grants (P20)
Project #
5P20MD004817-03
Application #
8375158
Study Section
Special Emphasis Panel (ZMD1-PA)
Project Start
Project End
Budget Start
2012-03-01
Budget End
2013-02-28
Support Year
3
Fiscal Year
2012
Total Cost
$52,831
Indirect Cost
$8,012
Name
Dillard University
Department
Type
DUNS #
062665468
City
New Orleans
State
LA
Country
United States
Zip Code
70122
Serrano-Gomez, Silvia Juliana; Sanabria-Salas, Maria Carolina; Hernández-Suarez, Gustavo et al. (2016) High prevalence of luminal B breast cancer intrinsic subtype in Colombian women. Carcinogenesis 37:669-76
Joseph, Ann Mary; Srivastava, Ratika; Zabaleta, Jovanny et al. (2016) Cross-talk between 4-1BB and TLR1-TLR2 Signaling in CD8+ T Cells Regulates TLR2's Costimulatory Effects. Cancer Immunol Res 4:708-16
Loupe, Jacob M; Miller, Patrick J; Bonner, Benjamin P et al. (2016) Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects. Oncotarget :
Loupe, J M; Miller, P J; Bonner, B P et al. (2016) Comparative transcriptomic analysis reveals the oncogenic fusion protein PAX3-FOXO1 globally alters mRNA and miRNA to enhance myoblast invasion. Oncogenesis 5:e246
Dai, Lu; Bai, Lihua; Lin, Zhen et al. (2016) Transcriptomic analysis of KSHV-infected primary oral fibroblasts: The role of interferon-induced genes in the latency of oncogenic virus. Oncotarget 7:47052-47060
Cruz-Rodriguez, Nataly; Combita, Alba L; Enciso, Leonardo J et al. (2016) High expression of ID family and IGJ genes signature as predictor of low induction treatment response and worst survival in adult Hispanic patients with B-acute lymphoblastic leukemia. J Exp Clin Cancer Res 35:64
Maxi, John K; Dean, Matt; Zabaleta, Jovanny et al. (2016) Chronic Binge Alcohol Administration Dysregulates Hippocampal Genes Involved in Immunity and Neurogenesis in Simian Immunodeficiency Virus-Infected Macaques. Biomolecules 6:
Garai, Jone; Uddo, Robert B; Mohler, Maura C et al. (2015) At the crossroad between obesity and gastric cancer. Methods Mol Biol 1238:689-707
Zabaleta, J; Velasco-Gonzalez, C; Estrada, J et al. (2014) Inverse correlation of serum inflammatory markers with metabolic parameters in healthy, Black and White prepubertal youth. Int J Obes (Lond) 38:563-8
Liu, Zun; Rebowe, Ryan E; Wang, Zemin et al. (2014) KIF3a promotes proliferation and invasion via Wnt signaling in advanced prostate cancer. Mol Cancer Res 12:491-503

Showing the most recent 10 out of 19 publications